PEGVISOMANT

PEGVISOMANT was reported 4106 times

PEGVISOMANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSULIN-LIKE GROWTH FACTOR ABNORMAL 70 0.6195
1 GROWTH HORMONE-PRODUCING PITUITARY TUMOUR 18 0.5625
2 ENDOCRINE GLAND OPERATION 3 0.3000
3 INSULIN-LIKE GROWTH FACTOR INCREASED 380 0.2663
4 BLOOD GROWTH HORMONE INCREASED 135 0.2419
5 INTERFERON GAMMA DECREASED 2 0.2222
6 PITUITARY GLAND OPERATION 6 0.2000
7 PITUITARY STALK INTERRUPTION SYNDROME 2 0.1333
8 ACROMEGALY 41 0.1293
9 INTERFERON GAMMA LEVEL INCREASED 2 0.1176
10 INSULIN-LIKE GROWTH FACTOR DECREASED 58 0.1096
11 PITUITARY TUMOUR RECURRENT 19 0.1092
12 INJECTION SITE HYPERTROPHY 28 0.0859
13 PROGNATHISM 8 0.0851
14 BLOOD GONADOTROPHIN DECREASED 2 0.0800
15 ANORECTAL POLYP 8 0.0748
16 BLOOD GROWTH HORMONE ABNORMAL 9 0.0738
17 HYPERPITUITARISM 2 0.0645
18 BLOOD PROLACTIN DECREASED 11 0.0629
19 BLOOD TESTOSTERONE FREE DECREASED 8 0.0611
20 LIPOHYPERTROPHY 37 0.0595
21 ENDOCRINE TEST ABNORMAL 2 0.0588
22 SENSITISATION 42 0.0553
23 FIBROUS DYSPLASIA OF BONE 4 0.0541
24 SHUNT MALFUNCTION 15 0.0530
25 GASTRIC HYPOMOTILITY 15 0.0489
26 PITUITARY TUMOUR 72 0.0483
27 ABNORMAL ORGAN GROWTH 2 0.0455
28 PITUITARY ENLARGEMENT 9 0.0441
29 VIRAL DIARRHOEA 15 0.0436
30 OXALOSIS 3 0.0395
31 LARYNGITIS BACTERIAL 2 0.0377
32 RECTAL POLYP 35 0.0355
33 BLOOD LUTEINISING HORMONE DECREASED 6 0.0335
34 PITUITARY TUMOUR BENIGN 54 0.0331
35 INJECTION SITE EROSION 11 0.0312
36 DEFICIENCY OF BILE SECRETION 3 0.0300
37 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III 2 0.0299
38 DEVICE CHEMICAL PROPERTY ISSUE 2 0.0299
39 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 8 0.0296
40 SHUNT OCCLUSION 15 0.0295
41 RENAL HAEMATOMA 15 0.0292
42 BONE DENSITY INCREASED 11 0.0276
43 INFECTED DERMAL CYST 9 0.0249
44 VISUAL PATHWAY DISORDER 4 0.0248
45 BLOOD GROWTH HORMONE DECREASED 5 0.0248
46 VITAL FUNCTIONS ABNORMAL 20 0.0234
47 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 4 0.0227
48 PITUITARY TUMOUR REMOVAL 2 0.0211
49 CHANGE OF BOWEL HABIT 43 0.0209
50 VERY LOW DENSITY LIPOPROTEIN INCREASED 4 0.0180
51 HYSTEROSALPINGO-OOPHORECTOMY 2 0.0179
52 OSTEOCHONDROMA 2 0.0168
53 ALBUMIN GLOBULIN RATIO DECREASED 3 0.0129
54 MINIMAL RESIDUAL DISEASE 6 0.0124
55 INJECTION SITE OEDEMA 21 0.0122
56 CENTRAL OBESITY 9 0.0122
57 PELVIC FLOOR MUSCLE WEAKNESS 2 0.0117
58 POLYP 75 0.0114
59 INTRACARDIAC MASS 2 0.0113
60 FAT TISSUE INCREASED 16 0.0110
61 ECLAMPSIA 4 0.0109
62 IMPAIRED FASTING GLUCOSE 3 0.0098
63 URINE ABNORMALITY 43 0.0094
64 GROWTH ACCELERATED 2 0.0093
65 EMPTY SELLA SYNDROME 2 0.0092
66 LIPODYSTROPHY ACQUIRED 19 0.0089
67 CRANIOFACIAL DEFORMITY 2 0.0086
68 HYPOTHALAMO-PITUITARY DISORDER 12 0.0082
69 BLOOD CHOLESTEROL ABNORMAL 38 0.0082
70 CAVERNOUS SINUS THROMBOSIS 2 0.0079
71 THYROXINE FREE INCREASED 5 0.0078
72 BREAST DISORDER FEMALE 2 0.0078
73 URINE ODOUR ABNORMAL 45 0.0076
74 NASAL SEPTUM DISORDER 2 0.0075
75 ACOUSTIC NEUROMA 3 0.0073
76 FRUSTRATION TOLERANCE DECREASED 58 0.0072
77 THYROXINE FREE DECREASED 4 0.0071
78 NEEDLE ISSUE 204 0.0070
79 MALOCCLUSION 2 0.0068
80 PROCTALGIA 42 0.0065
81 PITUITARY HAEMORRHAGE 2 0.0065
82 ADRENAL NEOPLASM 3 0.0064
83 CALCINOSIS 14 0.0063
84 POSTOPERATIVE WOUND INFECTION 42 0.0062
85 BREATH ODOUR 15 0.0061
86 CORTISOL DECREASED 7 0.0061
87 BODY HEIGHT INCREASED 3 0.0061
88 DUODENAL ULCER 43 0.0061
89 INFREQUENT BOWEL MOVEMENTS 15 0.0060
90 ADENOMA BENIGN 5 0.0058
91 TRI-IODOTHYRONINE DECREASED 3 0.0057
92 MUSCLE HYPERTROPHY 2 0.0057
93 FURUNCLE 45 0.0057
94 HELICOBACTER INFECTION 57 0.0055
95 LACTOSE INTOLERANCE 14 0.0055
96 BODY DYSMORPHIC DISORDER 2 0.0053
97 SOFT TISSUE SWELLING 3 0.0053
98 BLOOD THYROID STIMULATING HORMONE DECREASED 24 0.0053
99 INJECTION SITE DISCOMFORT 54 0.0051
100 ADRENOCORTICAL INSUFFICIENCY ACUTE 10 0.0051
101 STRABISMUS 15 0.0051
102 DEVICE COLOUR ISSUE 2 0.0050
103 HYPOGONADISM 5 0.0049
104 FAECES PALE 11 0.0049
105 BLOOD BILIRUBIN DECREASED 3 0.0049
106 THYROXINE DECREASED 3 0.0048
107 EXOSTOSIS 44 0.0048
108 CORTISOL INCREASED 3 0.0048
109 NEOPLASM 54 0.0047
110 RUBBER SENSITIVITY 7 0.0046
111 PHONOPHOBIA 2 0.0043
112 BLADDER DISORDER 42 0.0042
113 OCULAR NEOPLASM 2 0.0042
114 BLOOD TESTOSTERONE INCREASED 9 0.0042
115 LAZINESS 7 0.0041
116 BLOOD TESTOSTERONE DECREASED 28 0.0041
117 HYPOPITUITARISM 7 0.0040
118 BRAIN NEOPLASM 36 0.0039
119 HORMONE LEVEL ABNORMAL 19 0.0039
120 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
121 DIABETES INSIPIDUS 9 0.0037
122 TUMOUR EXCISION 3 0.0037
123 CONCOMITANT DISEASE AGGRAVATED 23 0.0037
124 NEOPLASM RECURRENCE 12 0.0035
125 COLONIC ABSCESS 3 0.0035
126 LOW DENSITY LIPOPROTEIN INCREASED 27 0.0035
127 THYROID DISORDER 53 0.0034
128 PERIPHERAL COLDNESS 47 0.0034
129 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
130 WEIGHT ABNORMAL 8 0.0033
131 DEVICE CONNECTION ISSUE 7 0.0033
132 GALLBLADDER DISORDER 59 0.0033
133 MASS 46 0.0033
134 POOR QUALITY PRODUCT ADMINISTERED 34 0.0032
135 BLOOD PROLACTIN INCREASED 15 0.0032
136 BLOOD PRESSURE SYSTOLIC INCREASED 62 0.0032
137 BLOOD ALKALINE PHOSPHATASE DECREASED 3 0.0032
138 BILE DUCT OBSTRUCTION 6 0.0032
139 BLOOD CORTISOL DECREASED 2 0.0031
140 OESOPHAGEAL ACHALASIA 2 0.0031
141 BILIARY COLIC 9 0.0031
142 BLOOD GLUCOSE FLUCTUATION 33 0.0030
143 DEVICE PHYSICAL PROPERTY ISSUE 23 0.0030
144 MAMMOGRAM ABNORMAL 2 0.0030
145 BRONCHITIS VIRAL 2 0.0030
146 HEART RATE DECREASED 104 0.0030
147 BLOOD CHLORIDE INCREASED 5 0.0029
148 INJECTION SITE INJURY 16 0.0029
149 SKIN HYPERTROPHY 8 0.0028
150 BILE DUCT STONE 9 0.0028
151 ALPHA 1 FOETOPROTEIN INCREASED 2 0.0028
152 NEOPLASM PROGRESSION 96 0.0028
153 MUSCULOSKELETAL DISCOMFORT 47 0.0027
154 BILIARY DILATATION 4 0.0027
155 CEREBROSPINAL FLUID LEAKAGE 5 0.0027
156 BONE DISORDER 49 0.0027
157 CHOLELITHIASIS 88 0.0027
158 CARBON DIOXIDE DECREASED 3 0.0026
159 HEPATIC ENZYME ABNORMAL 13 0.0026
160 BLOOD CREATININE DECREASED 8 0.0026
161 ARTERIAL OCCLUSIVE DISEASE 20 0.0025
162 DEVICE DISPENSING ERROR 3 0.0025
163 BILE DUCT CANCER 3 0.0025
164 INJECTION SITE MASS 92 0.0025
165 LIQUID PRODUCT PHYSICAL ISSUE 18 0.0025
166 BLOOD PARATHYROID HORMONE INCREASED 7 0.0024
167 HIGH DENSITY LIPOPROTEIN DECREASED 8 0.0024
168 SYRINGE ISSUE 42 0.0024
169 NECK INJURY 7 0.0024
170 THYROID MASS 9 0.0023
171 FAECES SOFT 17 0.0023
172 NOCTURIA 28 0.0023
173 POLYDIPSIA 9 0.0023
174 SPINAL OSTEOARTHRITIS 20 0.0023
175 SLEEP APNOEA SYNDROME 42 0.0022
176 GOITRE 9 0.0022
177 CLUSTER HEADACHE 3 0.0022
178 EYE MOVEMENT DISORDER 15 0.0022
179 BLOOD PRESSURE DIASTOLIC INCREASED 10 0.0022
180 PREMATURE MENOPAUSE 2 0.0022
181 INJECTION SITE CELLULITIS 4 0.0022
182 SNORING 8 0.0021
183 LIPOATROPHY 2 0.0021
184 WOUND INFECTION 23 0.0021
185 GLYCOSYLATED HAEMOGLOBIN INCREASED 53 0.0021
186 FULL BLOOD COUNT DECREASED 42 0.0021
187 FAECES DISCOLOURED 45 0.0021
188 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 35 0.0020
189 SKIN STRIAE 3 0.0020
190 HAEMANGIOMA OF LIVER 2 0.0020
191 BLOOD CHLORIDE DECREASED 5 0.0019
192 BODY TEMPERATURE DECREASED 19 0.0019
193 DIABETES MELLITUS 147 0.0019
194 AXILLARY MASS 2 0.0019
195 RENAL CYST 15 0.0019
196 ALLERGY TO ANIMAL 2 0.0019
197 OBSESSIVE-COMPULSIVE DISORDER 15 0.0019
198 INJECTION SITE ATROPHY 3 0.0018
199 THYROID NEOPLASM 5 0.0018
200 CHOLECYSTITIS INFECTIVE 5 0.0018
201 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
202 MUSCLE RUPTURE 7 0.0018
203 BRAIN INJURY 18 0.0018
204 POOR QUALITY DEVICE USED 18 0.0018
205 ESSENTIAL TREMOR 2 0.0018
206 CLEFT LIP AND PALATE 2 0.0018
207 JAUNDICE 48 0.0018
208 LIMB DISCOMFORT 55 0.0018
209 INJECTION SITE SCAR 5 0.0018
210 INJECTION SITE BRUISING 139 0.0017
211 LICHEN PLANUS 4 0.0017
212 DILATATION ATRIAL 2 0.0017
213 GROIN ABSCESS 2 0.0017
214 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
215 LABILE BLOOD PRESSURE 2 0.0017
216 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
217 DEVICE LEAKAGE 73 0.0017
218 PRODUCT PREPARATION ISSUE 11 0.0017
219 TOOTH ABSCESS 17 0.0017
220 PRODUCT DOSE OMISSION IN ERROR 47 0.0017
221 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
222 HEPATIC ENZYME INCREASED 111 0.0016
223 FOOT DEFORMITY 18 0.0016
224 INJECTION SITE INDURATION 21 0.0016
225 INJECTION SITE ABSCESS 4 0.0016
226 CHOLECYSTITIS ACUTE 9 0.0016
227 POLYURIA 13 0.0016
228 ENDOCRINE DISORDER 2 0.0016
229 CALCIUM DEFICIENCY 2 0.0015
230 BILIARY OBSTRUCTION 2 0.0015
231 VITAMIN D DECREASED 13 0.0015
232 INTERCEPTED PRODUCT PRESCRIBING ERROR 2 0.0015
233 PYELONEPHRITIS 13 0.0015
234 TRIGEMINAL NEURALGIA 6 0.0015
235 LIPIDS INCREASED 3 0.0015
236 POSTPARTUM HAEMORRHAGE 2 0.0015
237 CARBON DIOXIDE INCREASED 2 0.0015
238 CALCULUS BLADDER 2 0.0015
239 CHEST INJURY 3 0.0014
240 TENDONITIS 22 0.0014
241 URINARY INCONTINENCE 42 0.0014
242 LOW DENSITY LIPOPROTEIN DECREASED 2 0.0014
243 MUSCULOSKELETAL PAIN 74 0.0014
244 BONE PAIN 82 0.0014
245 EXOPHTHALMOS 3 0.0014
246 POST HERPETIC NEURALGIA 2 0.0014
247 HORDEOLUM 6 0.0014
248 MUTISM 2 0.0014
249 MONOCYTE COUNT INCREASED 5 0.0014
250 LIMB MASS 3 0.0014
251 BLOOD PRESSURE INCREASED 206 0.0013
252 CHOLANGIOCARCINOMA 2 0.0013
253 LUNG NEOPLASM MALIGNANT 55 0.0013
254 BLOOD GLUCOSE DECREASED 64 0.0013
255 DYSURIA 49 0.0013
256 HEPATOCELLULAR DAMAGE 3 0.0013
257 ASTIGMATISM 2 0.0013
258 HAEMATOCRIT INCREASED 3 0.0013
259 HEAT STROKE 2 0.0013
260 HYPERTROPHIC CARDIOMYOPATHY 2 0.0013
261 PRODUCT DEPOSIT 2 0.0013
262 INJECTION SITE HYPERSENSITIVITY 4 0.0013
263 JAW DISORDER 7 0.0013
264 DEVICE DEFECTIVE 22 0.0013
265 MYOPIA 3 0.0013
266 PANNICULITIS 3 0.0012
267 INJECTION SITE INFLAMMATION 6 0.0012
268 ANXIETY DISORDER 4 0.0012
269 BLOOD TRIGLYCERIDES INCREASED 21 0.0012
270 LABYRINTHITIS 3 0.0012
271 FEELING COLD 33 0.0012
272 EATING DISORDER 25 0.0012
273 LACK OF INJECTION SITE ROTATION 2 0.0011
274 ERUCTATION 22 0.0011
275 AORTIC VALVE STENOSIS 2 0.0011
276 BLOOD SODIUM INCREASED 3 0.0011
277 ARTHRITIS 87 0.0011
278 HAEMOGLOBIN INCREASED 5 0.0011
279 BLOOD IRON DECREASED 13 0.0011
280 RHINALGIA 3 0.0011
281 PRODUCT USE ISSUE 203 0.0011
282 ADENOCARCINOMA OF COLON 2 0.0011
283 SCIATICA 17 0.0011
284 GASTROENTERITIS VIRAL 19 0.0011
285 PANCREATIC CYST 2 0.0010
286 ADRENAL DISORDER 2 0.0010
287 HEPATIC MASS 2 0.0010
288 FINE MOTOR SKILL DYSFUNCTION 3 0.0010
289 BLOOD CHOLESTEROL INCREASED 48 0.0010
290 BLOOD GLUCOSE ABNORMAL 19 0.0010
291 AFFECTIVE DISORDER 8 0.0010
292 BLOOD TEST ABNORMAL 14 0.0010
293 PRODUCT SOLUBILITY ABNORMAL 5 0.0010
294 LIBIDO INCREASED 2 0.0010
295 OCULAR DISCOMFORT 11 0.0010
296 LIVER FUNCTION TEST INCREASED 21 0.0010
297 IRON DEFICIENCY ANAEMIA 9 0.0010
298 CHOLANGITIS 6 0.0010
299 PRODUCT DISPENSING ERROR 21 0.0010
300 INTENTIONAL PRODUCT MISUSE 83 0.0009
301 HYPERHIDROSIS 121 0.0009
302 BODY TEMPERATURE INCREASED 19 0.0009
303 POOR QUALITY DRUG ADMINISTERED 6 0.0009
304 BLOOD MAGNESIUM DECREASED 8 0.0009
305 LIMB INJURY 25 0.0009
306 HEPATIC NEOPLASM 3 0.0009
307 HIP ARTHROPLASTY 14 0.0009
308 INTENTIONAL DOSE OMISSION 26 0.0009
309 PRODUCT DOSE OMISSION ISSUE 268 0.0009
310 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 64 0.0009
311 MENINGITIS 6 0.0009
312 INFECTIOUS MONONUCLEOSIS 2 0.0009
313 ABDOMINAL DISTENSION 93 0.0009
314 BLOOD CALCIUM DECREASED 10 0.0009
315 ABDOMINAL HERNIA 4 0.0009
316 CHOLECYSTECTOMY 10 0.0009
317 EAR DISORDER 4 0.0009
318 TEMPERATURE INTOLERANCE 9 0.0009
319 LARGE INTESTINE POLYP 6 0.0009
320 HAEMANGIOMA 2 0.0009
321 HYPERVENTILATION 5 0.0009
322 CONTUSION 83 0.0009
323 INJECTION SITE REACTION 59 0.0009
324 ILLNESS 88 0.0009
325 HEPATOTOXICITY 19 0.0009
326 INJECTION SITE PAIN 261 0.0009
327 PANCREATITIS CHRONIC 2 0.0008
328 DIVERTICULUM 6 0.0008
329 PERIPHERAL SWELLING 128 0.0008
330 HEPATITIS CHOLESTATIC 5 0.0008
331 INJECTION SITE HAEMORRHAGE 66 0.0008
332 BURSITIS 10 0.0008
333 ADRENAL INSUFFICIENCY 10 0.0008
334 DEVICE BREAKAGE 33 0.0008
335 PRODUCT DOSE OMISSION 53 0.0008
336 PRE-EXISTING CONDITION IMPROVED 5 0.0008
337 PARANASAL SINUS HYPERSECRETION 3 0.0008
338 ABDOMINAL INFECTION 2 0.0008
339 PHLEBITIS 4 0.0008
340 SKELETAL INJURY 8 0.0008
341 LIPOMA 2 0.0008
342 EAR PAIN 15 0.0008
343 FAECES HARD 3 0.0008
344 HEPATITIS TOXIC 2 0.0008
345 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
346 CHOLECYSTITIS 9 0.0008
347 BLOOD PRESSURE ABNORMAL 15 0.0008
348 NASAL DISORDER 2 0.0008
349 PRODUCT COMPLAINT 19 0.0007
350 INTRACRANIAL ANEURYSM 3 0.0007
351 ANAL FISSURE 4 0.0007
352 LARYNGOSPASM 2 0.0007
353 BLOOD SODIUM DECREASED 14 0.0007
354 HIP SURGERY 4 0.0007
355 PRESCRIBED OVERDOSE 14 0.0007
356 ARTHRALGIA 300 0.0007
357 NEOPLASM MALIGNANT 48 0.0007
358 VITAMIN D DEFICIENCY 7 0.0007
359 BLOOD UREA INCREASED 12 0.0007
360 BLOOD PRESSURE FLUCTUATION 17 0.0007
361 LIGAMENT SPRAIN 7 0.0007
362 JOINT LOCK 2 0.0007
363 ABSCESS LIMB 3 0.0007
364 SHOULDER OPERATION 3 0.0007
365 FEAR OF INJECTION 5 0.0007
366 DRUG RESISTANCE 18 0.0007
367 PRODUCT CONTAINER ISSUE 6 0.0007
368 UNDERDOSE 51 0.0007
369 HEART VALVE INCOMPETENCE 2 0.0007
370 NEPHROLITHIASIS 32 0.0007
371 FIBULA FRACTURE 2 0.0007
372 HYPERTONIC BLADDER 2 0.0007
373 INJECTION SITE HAEMATOMA 10 0.0007
374 SLUGGISHNESS 7 0.0007
375 CARDIAC FAILURE 55 0.0007
376 LUMBAR SPINAL STENOSIS 2 0.0007
377 BLOOD CALCIUM INCREASED 6 0.0007
378 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
379 SUSPECTED OFF LABEL USE 3 0.0007
380 DRUG INTOLERANCE 64 0.0007
381 INCONTINENCE 7 0.0007
382 NECK PAIN 37 0.0007
383 DISEASE COMPLICATION 3 0.0007
384 BODY HEIGHT DECREASED 7 0.0007
385 BOWEL MOVEMENT IRREGULARITY 5 0.0007
386 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
387 CARDIOMEGALY 8 0.0006
388 BLOOD GLUCOSE INCREASED 122 0.0006
389 HEADACHE 404 0.0006
390 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
391 GAIT DISTURBANCE 123 0.0006
392 BRADYCARDIA 34 0.0006
393 INJECTION SITE NODULE 7 0.0006
394 FLATULENCE 36 0.0006
395 FAECAL CALPROTECTIN INCREASED 2 0.0006
396 PRODUCT PACKAGING ISSUE 6 0.0006
397 GESTATIONAL DIABETES 3 0.0006
398 EYE INFLAMMATION 6 0.0006
399 DEVICE USE ISSUE 11 0.0006
400 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 29 0.0006
401 LOOSE TOOTH 2 0.0006
402 PORTAL VEIN THROMBOSIS 2 0.0006
403 HEPATITIS ACUTE 4 0.0006
404 DRUG DOSE OMISSION BY DEVICE 48 0.0006
405 LABORATORY TEST ABNORMAL 18 0.0006
406 PANCREATIC DISORDER 3 0.0006
407 INCORRECT PRODUCT STORAGE 8 0.0006
408 CORONAVIRUS INFECTION 4 0.0006
409 CYTOLYTIC HEPATITIS 2 0.0006
410 ATRIAL FIBRILLATION 58 0.0006
411 BACK PAIN 138 0.0006
412 HAEMORRHAGE 62 0.0006
413 DYSLIPIDAEMIA 3 0.0006
414 MUSCULAR WEAKNESS 67 0.0006
415 JOINT SWELLING 71 0.0006
416 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
417 VARICOSE VEIN 3 0.0006
418 ENCEPHALITIS 4 0.0006
419 HYPERGLYCAEMIA 21 0.0006
420 TONSILLITIS 3 0.0006
421 HAEMOGLOBIN DECREASED 59 0.0006
422 INFLUENZA 64 0.0006
423 OSTEOARTHRITIS 24 0.0006
424 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
425 TYPE 2 DIABETES MELLITUS 19 0.0006
426 PRODUCT CONTAMINATION 2 0.0006
427 JOINT INJURY 12 0.0006
428 OFF LABEL USE 491 0.0006
429 ABDOMINAL DISCOMFORT 94 0.0006
430 INJECTION SITE DISCOLOURATION 7 0.0006
431 SUBDURAL HAEMATOMA 8 0.0006
432 PARALYSIS 8 0.0006
433 INJECTION SITE DISCHARGE 3 0.0006
434 HAEMATOCRIT DECREASED 11 0.0006
435 BACK DISORDER 9 0.0006
436 TONGUE DISORDER 4 0.0006
437 NORMAL NEWBORN 3 0.0006
438 NASOPHARYNGITIS 101 0.0005
439 HEPATITIS 14 0.0005
440 PRODUCT PRESCRIBING ERROR 13 0.0005
441 PRODUCT PHYSICAL ISSUE 11 0.0005
442 SWELLING 51 0.0005
443 DEAFNESS UNILATERAL 3 0.0005
444 INJECTION SITE SWELLING 41 0.0005
445 ABDOMINAL PAIN UPPER 110 0.0005
446 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
447 HEPATIC CIRRHOSIS 10 0.0005
448 PARANASAL SINUS DISCOMFORT 2 0.0005
449 HYPOAESTHESIA 79 0.0005
450 URINARY TRACT INFECTION 90 0.0005
451 RHINORRHOEA 34 0.0005
452 CARDIAC VALVE DISEASE 3 0.0005
453 CLAVICLE FRACTURE 2 0.0005
454 ARTHROPATHY 29 0.0005
455 OESOPHAGEAL ULCER 2 0.0005
456 BLOOD URIC ACID INCREASED 3 0.0005
457 HYPOGLYCAEMIA 25 0.0005
458 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 92 0.0005
459 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
460 HUNGER 7 0.0005
461 THYROID CANCER 6 0.0005
462 FATIGUE 387 0.0005
463 GALLBLADDER OPERATION 2 0.0005
464 TENSION 3 0.0005
465 WEIGHT INCREASED 110 0.0005
466 CHROMATURIA 11 0.0005
467 PRODUCT PREPARATION ERROR 10 0.0005
468 ANAPHYLACTOID REACTION 2 0.0005
469 AORTIC DISSECTION 2 0.0005
470 LIVER FUNCTION TEST ABNORMAL 14 0.0005
471 WEIGHT FLUCTUATION 5 0.0005
472 DYSPNOEA EXERTIONAL 18 0.0005
473 OROPHARYNGEAL PAIN 43 0.0005
474 WEIGHT DECREASED 129 0.0005
475 PAIN IN JAW 13 0.0005
476 MALAISE 201 0.0005
477 IMMOBILE 2 0.0005
478 DIVERTICULUM INTESTINAL 2 0.0005
479 GASTROINTESTINAL PAIN 5 0.0005
480 PRODUCT COMMUNICATION ISSUE 4 0.0005
481 LIGAMENT RUPTURE 2 0.0005
482 MUSCULOSKELETAL CHEST PAIN 7 0.0005
483 UPPER LIMB FRACTURE 9 0.0005
484 DEHYDRATION 60 0.0004
485 SKIN MASS 3 0.0004
486 FACIAL PAIN 4 0.0004
487 BRAIN FOG 7 0.0004
488 RASH PAPULAR 10 0.0004
489 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
490 COUGH 125 0.0004
491 HEAVY MENSTRUAL BLEEDING 4 0.0004
492 DRUG EFFECT DELAYED 2 0.0004
493 IMPAIRED GASTRIC EMPTYING 6 0.0004
494 INFARCTION 3 0.0004
495 DEVICE MECHANICAL ISSUE 6 0.0004
496 CELLULITIS 22 0.0004
497 ONYCHOCLASIS 3 0.0004
498 DIVERTICULITIS 12 0.0004
499 INJECTION SITE PRURITUS 29 0.0004
500 LOCALISED OEDEMA 2 0.0004
501 HYPERTRANSAMINASAEMIA 3 0.0004
502 ABDOMINAL PAIN 100 0.0004
503 EXTRASYSTOLES 3 0.0004
504 HEPATIC FUNCTION ABNORMAL 16 0.0004
505 LIVER DISORDER 19 0.0004
506 CARPAL TUNNEL SYNDROME 6 0.0004
507 FEELING ABNORMAL 102 0.0004
508 NASAL CONGESTION 25 0.0004
509 PRE-ECLAMPSIA 2 0.0004
510 RED BLOOD CELL COUNT DECREASED 12 0.0004
511 LIMB OPERATION 2 0.0004
512 DEPRESSED MOOD 22 0.0004
513 AMNESIA 27 0.0004
514 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
515 PAIN IN EXTREMITY 122 0.0004
516 MAJOR DEPRESSION 3 0.0004
517 UTERINE LEIOMYOMA 3 0.0004
518 COVID-19 72 0.0004
519 INCORRECT DOSAGE ADMINISTERED 2 0.0004
520 ALANINE AMINOTRANSFERASE INCREASED 25 0.0004
521 HYPOTHYROIDISM 13 0.0004
522 PSYCHIATRIC SYMPTOM 3 0.0004
523 NASAL POLYPS 2 0.0004
524 TRANSAMINASES INCREASED 9 0.0004
525 HYPERVOLAEMIA 2 0.0004
526 MUCOUS STOOLS 2 0.0004
527 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
528 ABDOMINAL TENDERNESS 2 0.0004
529 DECREASED APPETITE 93 0.0004
530 DIARRHOEA 256 0.0004
531 PRODUCT ADMINISTRATION ERROR 8 0.0004
532 HEAD DISCOMFORT 7 0.0004
533 INJECTION SITE IRRITATION 5 0.0004
534 SUBARACHNOID HAEMORRHAGE 4 0.0004
535 THIRST 7 0.0004
536 INJECTION SITE RASH 12 0.0004
537 ENDOCARDITIS 2 0.0004
538 PRODUCT COLOUR ISSUE 2 0.0004
539 ERECTILE DYSFUNCTION 10 0.0004
540 CATARACT 23 0.0004
541 PERIORBITAL OEDEMA 2 0.0004
542 VENTRICULAR EXTRASYSTOLES 4 0.0004
543 NODULE 5 0.0004
544 CONSTIPATION 83 0.0004
545 GASTROINTESTINAL DISORDER 34 0.0004
546 FEELING HOT 23 0.0004
547 FOOD POISONING 2 0.0004
548 HIP FRACTURE 12 0.0004
549 OVERWEIGHT 2 0.0004
550 PHOTOPHOBIA 7 0.0004
551 BLOOD BILIRUBIN INCREASED 10 0.0004
552 SINUS CONGESTION 5 0.0004
553 BEHAVIOUR DISORDER 2 0.0004
554 DECUBITUS ULCER 3 0.0004
555 DEVICE ISSUE 33 0.0004
556 HYDROCEPHALUS 2 0.0004
557 ABNORMAL FAECES 3 0.0004
558 BLOOD POTASSIUM DECREASED 11 0.0004
559 HICCUPS 3 0.0004
560 DEVICE DIFFICULT TO USE 24 0.0004
561 HYPERKERATOSIS 2 0.0004
562 HERNIA 7 0.0004
563 NERVE INJURY 4 0.0004
564 HAEMORRHOIDS 7 0.0004
565 MYALGIA 61 0.0004
566 DRUG EFFECT INCOMPLETE 13 0.0004
567 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
568 SENSATION OF FOREIGN BODY 3 0.0004
569 EYE INFECTION 4 0.0004
570 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
571 SEASONAL ALLERGY 5 0.0004
572 SWOLLEN TONGUE 11 0.0004
573 GASTRIC DISORDER 12 0.0003
574 CARDIAC OPERATION 3 0.0003
575 EXERCISE TOLERANCE DECREASED 2 0.0003
576 EXPOSURE VIA SKIN CONTACT 9 0.0003
577 PAIN 213 0.0003
578 MOUTH SWELLING 2 0.0003
579 HYSTERECTOMY 3 0.0003
580 MENTAL DISORDER 15 0.0003
581 INJURY ASSOCIATED WITH DEVICE 7 0.0003
582 INCORRECT DOSE ADMINISTERED BY DEVICE 9 0.0003
583 NAIL DISORDER 3 0.0003
584 FALL 113 0.0003
585 DECREASED INTEREST 2 0.0003
586 ARRHYTHMIA 16 0.0003
587 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
588 CARDIAC PACEMAKER INSERTION 2 0.0003
589 MACULAR DEGENERATION 4 0.0003
590 KNEE ARTHROPLASTY 7 0.0003
591 DRUG INEFFECTIVE 438 0.0003
592 BLOOD PRESSURE DECREASED 22 0.0003
593 INJECTION SITE VESICLES 2 0.0003
594 SKIN DISORDER 11 0.0003
595 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
596 RETINAL DETACHMENT 3 0.0003
597 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
598 NERVOUSNESS 17 0.0003
599 MENISCUS INJURY 2 0.0003
600 SPINAL OPERATION 4 0.0003
601 ASTHENIA 122 0.0003
602 EMOTIONAL DISORDER 10 0.0003
603 PIGMENTATION DISORDER 2 0.0003
604 VISUAL IMPAIRMENT 40 0.0003
605 CONDITION AGGRAVATED 98 0.0003
606 DIARRHOEA HAEMORRHAGIC 3 0.0003
607 DRY EYE 16 0.0003
608 MEMORY IMPAIRMENT 44 0.0003
609 FLANK PAIN 3 0.0003
610 BLINDNESS 13 0.0003
611 DERMATITIS ALLERGIC 4 0.0003
612 PRODUCT USE COMPLAINT 5 0.0003
613 SPINAL DISORDER 3 0.0003
614 DISEASE RECURRENCE 15 0.0003
615 ABSCESS 5 0.0003
616 DISEASE PROGRESSION 37 0.0003
617 AFFECT LABILITY 3 0.0003
618 GLAUCOMA 6 0.0003
619 GALACTORRHOEA 2 0.0003
620 SINUS BRADYCARDIA 3 0.0003
621 NIGHT SWEATS 10 0.0003
622 DIZZINESS POSTURAL 3 0.0003
623 BLOOD POTASSIUM INCREASED 5 0.0003
624 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
625 VITREOUS FLOATERS 3 0.0003
626 KNEE OPERATION 3 0.0003
627 INFLUENZA LIKE ILLNESS 25 0.0003
628 PYREXIA 105 0.0003
629 SARS-COV-2 TEST POSITIVE 4 0.0003
630 SINUSITIS 31 0.0003
631 HYPOACUSIS 13 0.0003
632 APPETITE DISORDER 2 0.0003
633 CEREBROVASCULAR ACCIDENT 51 0.0003
634 EAR INFECTION 8 0.0003
635 HYPOTONIA 3 0.0003
636 OVARIAN CYST 3 0.0003
637 GAIT INABILITY 10 0.0003
638 DIZZINESS 148 0.0003
639 EYELID PTOSIS 3 0.0003
640 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
641 MIGRAINE 28 0.0003
642 CHEST DISCOMFORT 30 0.0003
643 NAUSEA 231 0.0003
644 INJECTION SITE ERYTHEMA 36 0.0003
645 HAIR GROWTH ABNORMAL 2 0.0003
646 CARDIAC DISORDER 27 0.0003
647 ROAD TRAFFIC ACCIDENT 12 0.0003
648 DEMENTIA 8 0.0003
649 CHEST PAIN 53 0.0003
650 AGITATION 21 0.0003
651 COLD SWEAT 5 0.0003
652 SUDDEN DEATH 3 0.0003
653 RENAL PAIN 3 0.0003
654 CYSTITIS 9 0.0003
655 HEPATOCELLULAR INJURY 4 0.0003
656 DIALYSIS 4 0.0003
657 BREAST PAIN 3 0.0003
658 THERAPEUTIC RESPONSE DECREASED 17 0.0003
659 HYPERSENSITIVITY 52 0.0003
660 ANGINA PECTORIS 8 0.0003
661 RENAL DISORDER 13 0.0003
662 POOR QUALITY SLEEP 6 0.0003
663 PANIC REACTION 2 0.0003
664 TREATMENT NONCOMPLIANCE 15 0.0003
665 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
666 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
667 CARDIOMYOPATHY 4 0.0003
668 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
669 BRONCHITIS 20 0.0003
670 ARTHROPOD BITE 2 0.0003
671 HEPATIC STEATOSIS 5 0.0003
672 COLON CANCER 4 0.0003
673 BLISTER 15 0.0003
674 JOINT STIFFNESS 7 0.0003
675 BREAST TENDERNESS 2 0.0003
676 ALOPECIA 52 0.0003
677 HYPERTENSION 56 0.0003
678 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
679 SCAB 3 0.0003
680 HEPATOCELLULAR CARCINOMA 2 0.0003
681 PNEUMONIA 85 0.0003
682 VERTIGO 16 0.0003
683 ACIDOSIS 2 0.0003
684 PROCEDURAL COMPLICATION 2 0.0003
685 SEIZURE 30 0.0003
686 TACHYCARDIA 23 0.0003
687 CONCUSSION 2 0.0003
688 APHTHOUS ULCER 2 0.0003
689 NERVOUS SYSTEM DISORDER 8 0.0003
690 DEVICE MALFUNCTION 18 0.0003
691 MENORRHAGIA 5 0.0003
692 SINUS DISORDER 5 0.0003
693 BLOOD ALBUMIN DECREASED 2 0.0003
694 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
695 GINGIVAL PAIN 2 0.0003
696 ATRIAL FLUTTER 2 0.0003
697 EYE PAIN 14 0.0002
698 SPEECH DISORDER 13 0.0002
699 NEURALGIA 6 0.0002
700 PANCREATITIS 13 0.0002
701 LETHARGY 14 0.0002
702 INJECTION SITE WARMTH 5 0.0002
703 PRODUCT QUALITY ISSUE 33 0.0002
704 PHARYNGITIS 3 0.0002
705 CYST 3 0.0002
706 MENSTRUAL DISORDER 2 0.0002
707 ILEUS 3 0.0002
708 ANAEMIA 46 0.0002
709 VISION BLURRED 33 0.0002
710 EOSINOPHIL COUNT INCREASED 2 0.0002
711 MUSCULOSKELETAL STIFFNESS 21 0.0002
712 PARAESTHESIA 37 0.0002
713 FACIAL PARALYSIS 2 0.0002
714 INFLAMMATION 12 0.0002
715 HIATUS HERNIA 3 0.0002
716 PRURITUS GENERALISED 5 0.0002
717 DIPLOPIA 6 0.0002
718 DEATH 199 0.0002
719 SYNCOPE 23 0.0002
720 AMENORRHOEA 4 0.0002
721 TOOTH INFECTION 3 0.0002
722 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
723 LYMPHADENOPATHY 8 0.0002
724 ANXIETY 64 0.0002
725 THROMBOSIS 18 0.0002
726 JOINT RANGE OF MOTION DECREASED 3 0.0002
727 GASTROINTESTINAL INFECTION 2 0.0002
728 THERAPY NON-RESPONDER 10 0.0002
729 HEART RATE IRREGULAR 5 0.0002
730 PULMONARY EMBOLISM 21 0.0002
731 GASTROINTESTINAL CARCINOMA 2 0.0002
732 LIP DRY 2 0.0002
733 OSTEOPOROSIS 9 0.0002
734 MOVEMENT DISORDER 7 0.0002
735 MUSCLE TWITCHING 5 0.0002
736 OVARIAN CANCER 2 0.0002
737 NERVE COMPRESSION 2 0.0002
738 FLUID RETENTION 11 0.0002
739 DYSARTHRIA 8 0.0002
740 HEART RATE INCREASED 21 0.0002
741 LEUKAEMIA 2 0.0002
742 FOOT FRACTURE 4 0.0002
743 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 15 0.0002
744 BLOOD URINE PRESENT 4 0.0002
745 MUSCULOSKELETAL DISORDER 4 0.0002
746 RECTAL HAEMORRHAGE 9 0.0002
747 INCREASED APPETITE 4 0.0002
748 CHOLESTASIS 4 0.0002
749 POST PROCEDURAL COMPLICATION 4 0.0002
750 LOWER LIMB FRACTURE 4 0.0002
751 DIABETIC KETOACIDOSIS 5 0.0002
752 HYPERTHYROIDISM 3 0.0002
753 HYPERCHOLESTEROLAEMIA 2 0.0002
754 ANGER 7 0.0002
755 DEPRESSION 47 0.0002
756 MENTAL IMPAIRMENT 5 0.0002
757 ASTHMA 23 0.0002
758 PULMONARY MASS 3 0.0002
759 SWELLING FACE 13 0.0002
760 BLOOD CREATININE INCREASED 13 0.0002
761 TREMOR 33 0.0002
762 SLEEP DISORDER 14 0.0002
763 INCORRECT DOSE ADMINISTERED 45 0.0002
764 CEREBRAL HAEMORRHAGE 7 0.0002
765 NEUTROPHIL COUNT INCREASED 2 0.0002
766 ANAPHYLACTIC SHOCK 5 0.0002
767 ANKLE FRACTURE 3 0.0002
768 INSOMNIA 51 0.0002
769 MUSCLE SPASMS 35 0.0002
770 JOINT DISLOCATION 2 0.0002
771 DYSPNOEA 107 0.0002
772 DECREASED ACTIVITY 2 0.0002
773 MENSTRUATION DELAYED 2 0.0002
774 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
775 VOMITING 86 0.0002
776 EYE DISORDER 6 0.0002
777 BREAST CANCER 17 0.0002
778 HAEMATOCHEZIA 10 0.0002
779 TREATMENT FAILURE 15 0.0002
780 HYPERTENSIVE CRISIS 2 0.0002
781 RENAL IMPAIRMENT 15 0.0002
782 PANCREATITIS ACUTE 4 0.0002
783 OXYGEN SATURATION DECREASED 10 0.0002
784 MITRAL VALVE INCOMPETENCE 2 0.0002
785 DISORIENTATION 7 0.0002
786 SCAR 3 0.0002
787 MICTURITION URGENCY 2 0.0002
788 PANCREATIC CARCINOMA 5 0.0002
789 LOSS OF CONSCIOUSNESS 22 0.0002
790 BACTERAEMIA 2 0.0002
791 POLLAKIURIA 7 0.0002
792 RESPIRATORY DISORDER 5 0.0002
793 MOBILITY DECREASED 12 0.0002
794 DISTURBANCE IN ATTENTION 9 0.0002
795 TOOTHACHE 3 0.0002
796 OSTEOMYELITIS 3 0.0002
797 LOCALISED INFECTION 4 0.0002
798 CRYING 6 0.0002
799 FIBROMYALGIA 4 0.0002
800 PRESYNCOPE 4 0.0002
801 DISCOMFORT 10 0.0002
802 INJECTION SITE EXTRAVASATION 2 0.0002
803 SEPSIS 18 0.0002
804 THINKING ABNORMAL 3 0.0002
805 BACTERIAL INFECTION 3 0.0002
806 FRACTURE 3 0.0002
807 COLITIS 6 0.0002
808 HEAD INJURY 5 0.0002
809 PROTEINURIA 3 0.0002
810 HEPATIC CYTOLYSIS 2 0.0002
811 INTRAOCULAR PRESSURE INCREASED 2 0.0002
812 OEDEMA PERIPHERAL 19 0.0002
813 URTICARIA 26 0.0002
814 SKIN ULCER 4 0.0002
815 DYSPHONIA 9 0.0002
816 PALPITATIONS 18 0.0002
817 CHILLS 18 0.0002
818 DEAFNESS 4 0.0002
819 KIDNEY INFECTION 3 0.0002
820 HAND DEFORMITY 2 0.0002
821 IMMUNE SYSTEM DISORDER 2 0.0002
822 DYSMENORRHOEA 2 0.0002
823 VISUAL ACUITY REDUCED 5 0.0002
824 VIRAL INFECTION 5 0.0002
825 COGNITIVE DISORDER 7 0.0001
826 ABORTION SPONTANEOUS 6 0.0001
827 SPINAL FRACTURE 3 0.0001
828 HAIR TEXTURE ABNORMAL 2 0.0001
829 MALIGNANT MELANOMA 2 0.0001
830 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
831 FEEDING DISORDER 3 0.0001
832 OEDEMA 8 0.0001
833 EPISTAXIS 11 0.0001
834 MOOD ALTERED 4 0.0001
835 HOT FLUSH 11 0.0001
836 RIB FRACTURE 3 0.0001
837 TOOTH LOSS 3 0.0001
838 APHONIA 2 0.0001
839 BLINDNESS UNILATERAL 2 0.0001
840 HERPES ZOSTER 8 0.0001
841 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
842 PRODUCT PRESCRIBING ISSUE 3 0.0001
843 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
844 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
845 SURGERY 8 0.0001
846 THERAPY CESSATION 7 0.0001
847 ERYTHEMA 28 0.0001
848 ASCITES 4 0.0001
849 EYE SWELLING 5 0.0001
850 PRURITUS 51 0.0001
851 INTESTINAL OBSTRUCTION 5 0.0001
852 DYSPEPSIA 13 0.0001
853 ACNE 10 0.0001
854 OSTEOPENIA 2 0.0001
855 DRUG DISPENSING ERROR 2 0.0001
856 SKIN DISCOLOURATION 6 0.0001
857 DEVICE RELATED INFECTION 2 0.0001
858 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
859 HYPOTENSION 26 0.0001
860 DELUSION 2 0.0001
861 DRUG-INDUCED LIVER INJURY 4 0.0001
862 DRUG DOSE OMISSION 21 0.0001
863 OCULAR HYPERAEMIA 6 0.0001
864 MYOCARDIAL INFARCTION 22 0.0001
865 OBESITY 2 0.0001
866 EXTRA DOSE ADMINISTERED 5 0.0001
867 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
868 INJECTION SITE URTICARIA 3 0.0001
869 LIVER INJURY 3 0.0001
870 PHOTOSENSITIVITY REACTION 2 0.0001
871 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
872 PNEUMONIA ASPIRATION 3 0.0001
873 RASH 52 0.0001
874 SOMNOLENCE 24 0.0001
875 GASTRIC CANCER 3 0.0001
876 CIRCULATORY COLLAPSE 2 0.0001
877 HAEMATURIA 4 0.0001
878 UNRESPONSIVE TO STIMULI 3 0.0001
879 BALANCE DISORDER 10 0.0001
880 DEVICE USE ERROR 4 0.0001
881 LOCAL SWELLING 2 0.0001
882 RENAL FAILURE 15 0.0001
883 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
884 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
885 ISCHAEMIC STROKE 2 0.0001
886 PULMONARY OEDEMA 5 0.0001
887 GOUT 2 0.0001
888 CONFUSIONAL STATE 18 0.0001
889 THROAT TIGHTNESS 3 0.0001
890 PALLOR 3 0.0001
891 PANIC ATTACK 4 0.0001
892 TINNITUS 5 0.0001
893 CONJUNCTIVITIS 2 0.0001
894 DYSPHAGIA 10 0.0001
895 GASTRIC ULCER 2 0.0001
896 NEUROPATHY PERIPHERAL 10 0.0001
897 PRODUCTIVE COUGH 5 0.0001
898 HYPERSOMNIA 3 0.0001
899 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
900 DRUG PRESCRIBING ERROR 2 0.0001
901 PRODUCT STORAGE ERROR 9 0.0001
902 DYSSTASIA 3 0.0001
903 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
904 LEUKOPENIA 5 0.0001
905 BURNING SENSATION 7 0.0001
906 CARDIAC FAILURE CONGESTIVE 8 0.0001
907 PROSTATE CANCER 8 0.0001
908 EPILEPSY 3 0.0001
909 DRY SKIN 13 0.0001
910 CARDIAC ARREST 8 0.0001
911 FEMUR FRACTURE 3 0.0001
912 EXPOSURE DURING PREGNANCY 6 0.0001
913 RESPIRATORY FAILURE 7 0.0001
914 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
915 DERMATITIS 2 0.0001
916 RENAL FAILURE ACUTE 4 0.0001
917 MOOD SWINGS 3 0.0001
918 IRRITABLE BOWEL SYNDROME 2 0.0001
919 DRUG EFFECT DECREASED 5 0.0001
920 DEEP VEIN THROMBOSIS 6 0.0001
921 SEPTIC SHOCK 4 0.0001
922 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
923 APPLICATION SITE PAIN 2 0.0001
924 URINARY RETENTION 3 0.0001
925 INFECTION 13 0.0001
926 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
927 SUICIDAL IDEATION 8 0.0001
928 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
929 DELIRIUM 3 0.0001
930 RASH MACULAR 3 0.0001
931 COMA 4 0.0001
932 RENAL CANCER 4 0.0001
933 IRRITABILITY 5 0.0001
934 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
935 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
936 C-REACTIVE PROTEIN INCREASED 3 0.0001
937 CEREBRAL INFARCTION 2 0.0001
938 ABASIA 2 0.0001
939 AGGRESSION 4 0.0001
940 CARDIOVASCULAR DISORDER 2 0.0001
941 BREAST CANCER FEMALE 2 0.0001
942 FEAR 2 0.0001
943 DRY MOUTH 6 0.0001
944 RASH PRURITIC 4 0.0001
945 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
946 HYPONATRAEMIA 4 0.0001
947 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
948 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
949 ANGIOEDEMA 3 0.0001
950 COLITIS ULCERATIVE 3 0.0001
951 ADVERSE DRUG REACTION 6 0.0001
952 PREMATURE BABY 2 0.0001
953 APHASIA 2 0.0001
954 LACRIMATION INCREASED 2 0.0001
955 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
956 PLATELET COUNT DECREASED 7 0.0001
957 DRUG ADMINISTRATION ERROR 2 0.0001
958 GYNAECOMASTIA 2 0.0001
959 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
960 RASH ERYTHEMATOUS 3 0.0001
961 LUNG DISORDER 3 0.0001
962 OVERDOSE 13 0.0001
963 FUNGAL INFECTION 2 0.0001
964 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
965 THERAPY INTERRUPTED 4 0.0001
966 PLASMA CELL MYELOMA 2 0.0001
967 WHEEZING 3 0.0001
968 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
969 EMOTIONAL DISTRESS 6 0.0000
970 STOMATITIS 3 0.0000
971 FLUSHING 5 0.0000
972 RHEUMATOID ARTHRITIS 5 0.0000
973 HALLUCINATION 3 0.0000
974 ACUTE KIDNEY INJURY 6 0.0000
975 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
976 HOSPITALISATION 6 0.0000
977 ANAPHYLACTIC REACTION 2 0.0000
978 PANCYTOPENIA 2 0.0000
979 BLADDER CANCER 2 0.0000
980 ILL-DEFINED DISORDER 2 0.0000
981 DRUG INTERACTION 5 0.0000
982 DYSGEUSIA 2 0.0000
983 THROMBOCYTOPENIA 3 0.0000
984 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
985 PSORIASIS 3 0.0000
986 NEUTROPENIA 3 0.0000
987 NO ADVERSE EVENT 3 0.0000
988 DRUG DEPENDENCE 2 0.0000